Maddie Kubiliun, M.D.
Assistant Professor

Dr. Kubiliun grew up in Miami, Florida and earned her medical degree from the University of Miami Miller School of Medicine. Following medical school, she moved to Dallas to complete both her residency in Internal Medicine, and fellowship in gastroenterology and hepatology at UT Southwestern. She went on to complete a fellowship in advanced liver disease and transplant hepatology at Massachusetts General Hospital. She joined the faculty at UT Southwestern in 2021, and specializes in non-alcoholic fatty liver disease, chronic liver disease, cirrhosis, and liver transplantation. She is dedicated to providing comprehensive and compassionate care to her patients, and brings enthusiasm for clinical research and program development. Her clinical and research interests are in fatty liver disease, cirrhosis, and liver transplantation.

 In addition to medicine, Dr. Kubiliun enjoys traveling, cooking, reading, and spending time with her family. 
 

Other Post Graduate Training

University of Florida (2010)

Medical School

University of Miami Miller School of Medicine (2014)

Residency

UT Southwestern Medical Center (2017), Internal Medicine

Fellowship

UT Southwestern Medical Center (2020), Gastroenterology/hepatology

Fellowship

Massachusetts General Hospital (2021), Transplant Hepatology

• Alcohol Asociated Liver Disease (ALD)
• Liver Transplantation
• Non-alcoholic Fatty Liver Disease (NAFLD)

Featured Publications

Pro: Liver Transplantation Should Be Considered in Select Patients With Acute Alcoholic Hepatitis.

Kubiliun MJ, Rich NE, Singal A, Mufti AR, Clin Liver Dis (Hoboken) 2019 May 13 5 140-143

Neurological autoimmune disorders with prominent gastrointestinal manifestations: A review of presentation, evaluation, and treatment.

Blackburn KM, Kubiliun M, Harris S, Vernino S, Neurogastroenterol. Motil. 2019 Apr e13611

Early liver transplantation for alcoholic hepatitis: Ready for primetime?

Kubiliun M, Patel SJ, Hur C, Dienstag JL, Luther J, J Hepatol 2018 03 68 3 380-382

Concentrations of 6-thioguanine nucleotide correlate with trough levels of infliximab in patients with inflammatory bowel disease on combination therapy.

Yarur AJ, Kubiliun MJ, Czul F, Sussman DA, Quintero MA, Jain A, Drake KA, Hauenstein SI, Lockton S, Deshpande AR, Barkin JS, Singh S, Abreu MT, Clin Gastroenterol Hepatol 2015 Jun 13 6 1118-24.e3

 Featured Books

Hepatocellular Carcinoma. In Schiff's Disease of the Liver

Kubiliun M, Marrero, J (2017).

• John S. Miller Award for Outstanding Senior Resident in Internal Medicine
  UT Southwestern (2017)

• American Society of Transplantation (2020)
• Amerian Association for the Study of Liver Disease (2017)
• American Gastroenterology Association (2017)